Drugs / Pramipexole ER
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT06705478 | May → Dec 2026 | HIV infectious disease, cognitive disorder, major depressive disorder | National Institute of Allergy and Infectious Diseases (NIAID) | Suspended | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Pramipexole ER | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06705478 ↗ |
| Route | Oral | “Tablets self-administered orally” NCT06705478 ↗ |